Ingrid E. Wertz
Pliant (United States)(US)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, NF-κB Signaling Pathways, Cancer-related Molecular Pathways, interferon and immune responses
Most-Cited Works
- → De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling(2004)1,816 cited
- → Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7(2011)808 cited
- → The ubiquitin ligase COP1 is a critical negative regulator of p53(2004)704 cited
- → Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease(2015)613 cited
- → Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies(2008)551 cited
- → Bcl10 activates the NF-κB pathway through ubiquitination of NEMO(2003)524 cited
- → Ubiquitination in the regulation of inflammatory cell death and cancer(2021)483 cited
- → Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death(2011)429 cited
- → Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)(2015)427 cited
- → Human De-Etiolated-1 Regulates c-Jun by Assembling a CUL4A Ubiquitin Ligase(2004)368 cited